Generate Biomedicines (GENB) Reiterated at Overweight by Cantor Fitzgerald Apr 2, 2026 08:02AM
Cantor Fitzgerald Starts Generate Biomedicines (GENB) at Overweight Mar 24, 2026 06:07AM
Generate Biomedicines prices IPO at $16 per share Feb 26, 2026 07:58PM
Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering Feb 26, 2026 07:58PM